Switching to riociguat versus maintenance therapy with phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension (REPLACE): a multicentre, open-label, randomised controlled trial.
- Resource Type
- Article
- Source
- Lancet Respiratory Medicine; Jun2021, Vol. 9 Issue 6, p573-584, 12p
- Subject
PULMONARY hypertension PHOSPHODIESTERASE-5 inhibitors INTERACTIVE voice response (Telecommunication) RESPIRATORY infections BRAIN natriuretic factor ENDOTHELIN receptors OBSTRUCTIVE lung diseases - Language
- ISSN
- 22132600